Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

PLC Systems' Heart Laser superior to holmium and excimer lasers for TMR

Oct. 25, 1996

No Comments

GV-1201/GV-1202 available for licensing

Oct. 25, 1996

No Comments

Gensia turns over development of Geomatrix nifedipine product

Oct. 25, 1996

No Comments

Phase IV study results reported for ramipril

Oct. 25, 1996

No Comments

Benzimidazole derivatives for use in heart failure

Oct. 18, 1996

No Comments

GenVec licenses human iNOS gene from University of Pittsburgh

Oct. 18, 1996

No Comments

Tsumura discloses agents for atherosclerosis

Oct. 18, 1996

No Comments

First low-dose hydrochlorothiazide product approvable

Oct. 18, 1996

No Comments

Antihypertensive combination cleared for marketing in the U.S.

Oct. 18, 1996

No Comments

PRAISE trial demonstrates safety of calcium channel blocker in severe heart failure

Oct. 18, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Cardiovascular
RSS

PLC Systems' Heart Laser superior to holmium and excimer lasers for TMR

GV-1201/GV-1202 available for licensing

Gensia turns over development of Geomatrix nifedipine product

Phase IV study results reported for ramipril

Benzimidazole derivatives for use in heart failure

GenVec licenses human iNOS gene from University of Pittsburgh

Tsumura discloses agents for atherosclerosis

First low-dose hydrochlorothiazide product approvable

Antihypertensive combination cleared for marketing in the U.S.

PRAISE trial demonstrates safety of calcium channel blocker in severe heart failure

Today's news in brief

Today's news in brief

J&J’s Ottava robotic system approved for US pivotal trial

In muscular dystrophies, gene therapies race the clock

‘Evo’ AI can design complete genomes

Cardiovascular RSS

Cardiovascular
RSS